Genomic Imaging
for Precision Medicine

Better tests.
Better treatments.
Better outcomes.

3D Signatures Inc. is a novel personalized medicine company with proprietary software that can analyze a patient’s chromosomal arrangement – or signature – through a simple non-invasive blood test or tissue sample, measuring disease stage and genomic stability, as well as drug efficacy and potential side effects.

Unlike most diagnostic companies, our proprietary imaging software goes beyond identifying whether a patient suffers from a specific disease or condition.

Our analytics platform tells doctors how to personalize treatment and best manage the disease for each individual patient.

Learn More >

Enabling Truly Personalized Medicine

Based on Dr. Sabine Mai’s groundbreaking research, 3D Signatures is the first and only company to understand and quantify normal versus disease state telomere arrangement, turning this into usable, predictable, reliable, and highly valuable information that can improve patient outcomes. This disruptive technology platform is fundamentally different from conventional diagnostic methods and could represent an entirely new class of biomarkers for diseases like cancer and Alzheimer’s.


Proprietary Platform Technology

$ 0 M+
in non-dilutive R&D funding
Clinical studies
0 +
Peer-reviewed papers